Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
0.9900
+0.0700 (7.61%)
At close: Apr 25, 2025, 4:00 PM
0.9801
-0.0099 (-1.00%)
After-hours: Apr 25, 2025, 4:23 PM EDT

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $6.36 million. The enterprise value is $7.19 million.

Market Cap 6.36M
Enterprise Value 7.19M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

BCLI has 6.52 million shares outstanding. The number of shares has increased by 74.87% in one year.

Current Share Class 6.52M
Shares Outstanding 6.52M
Shares Change (YoY) +74.87%
Shares Change (QoQ) +7.50%
Owned by Insiders (%) 12.84%
Owned by Institutions (%) 10.91%
Float 5.55M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio -0.82
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio 0.04
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -151.86

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -241.99%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 163.63%
Revenue Per Employee n/a
Profits Per Employee -$430,481
Employee Count 27
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -87.89% in the last 52 weeks. The beta is 0.59, so BCLI's price volatility has been lower than the market average.

Beta (5Y) 0.59
52-Week Price Change -87.89%
50-Day Moving Average 1.36
200-Day Moving Average 2.56
Relative Strength Index (RSI) 40.87
Average Volume (20 Days) 375,790

Short Selling Information

The latest short interest is 346,646, so 5.31% of the outstanding shares have been sold short.

Short Interest 346,646
Short Previous Month 137,216
Short % of Shares Out 5.31%
Short % of Float 6.24%
Short Ratio (days to cover) 1.05

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -11.69M
Pretax Income -15.53M
Net Income -11.62M
EBITDA -11.45M
EBIT -11.69M
Earnings Per Share (EPS) -$2.31
Full Income Statement

Balance Sheet

The company has $187,000 in cash and $1.02 million in debt, giving a net cash position of -$833,000 or -$0.13 per share.

Cash & Cash Equivalents 187,000
Total Debt 1.02M
Net Cash -833,000
Net Cash Per Share -$0.13
Equity (Book Value) -7.76M
Book Value Per Share -1.26
Working Capital -8.59M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.09M
Capital Expenditures n/a
Free Cash Flow -9.09M
FCF Per Share -$1.39
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -74.87%
Shareholder Yield n/a
Earnings Yield -182.77%
FCF Yield -142.99%

Analyst Forecast

The average price target for BCLI is $30.00, which is 2,930.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target $30.00
Price Target Difference 2,930.30%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Oct 1, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1